- Science
- Global
TriPcides target MRSA, suppress infection and kill dormant bacteria to open a new front against antibiotic resistance
- May 19, 2026 at 8:00 PM
- 48 views
In a new study, researchers show how so‑called TriPcides can target the bacterium Staphylococcus aureus, including antibiotic‑resistant strains such as MRSA. The compounds disrupt the bacteria's ability to cause infection and can also kill dormant bacterial cells, which are often difficult to treat with existing antibiotics.
Originally published at Phys.org